首页> 美国卫生研究院文献>other >Inclusion of epitopes that expand high avidity CD4+ T cells transforms sub-protective vaccines to efficacious immunogens against virulent Francisella tularensis
【2h】

Inclusion of epitopes that expand high avidity CD4+ T cells transforms sub-protective vaccines to efficacious immunogens against virulent Francisella tularensis

机译:包含可扩展高亲和力CD4 + T细胞的表位可将亚保护性疫苗转化为针对强毒弗朗西斯菌的有效免疫原

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

T cells are the immunological cornerstone in host defense against infections by intracellular bacterial pathogens, such as virulent Francisella tularensis (Ftt). The general paucity of novel vaccines for Ftt over the past 60 years can, in part, be attributed to the poor understanding of immune parameters required to survive infection. Thus, we developed a strategy utilizing classical immunological tools to elucidate requirements for effective adaptive immune responses directed against Ftt. Following generation of various Francisella strains expressing well-characterized lymphocytic choriomeningitis virus (LCMV) epitopes, we found that survival correlated with persistence of antigen-specific CD4+ T cells. Function of these cells was confirmed in their ability to more effectively control Ftt replication in vitro. The importance of understanding the antigen-specific response was underscored by our observation that inclusion of an epitope which elicits high avidity CD4+ T cells converted a poorly protective vaccine to one that engenders 100% protection. Together, these data suggest that improved efficacy of current tularemia vaccine platforms will require targeting appropriate antigen-specific CD4+ T cell responses and that elucidation of Francisella epitopes that elicit high avidity CD4+ T cell responses, specifically in humans, will be required for successful vaccine development.
机译:T细胞是宿主防御细胞内细菌病原体(例如强毒弗朗西斯菌(Ftt))感染的免疫学基础。在过去的60年中,用于Ftt的新型疫苗普遍缺乏,部分原因是人们对感染后生存所需的免疫参数了解不足。因此,我们开发了一种策略,利用经典的免疫学工具阐明了针对Ftt的有效适应性免疫应答的要求。在产生表达特征明确的淋巴细胞性脉络膜脑膜炎病毒(LCMV)表位的各种弗朗西斯菌菌株后,我们发现存活与抗原特异性CD4 + T细胞的持久性相关。这些细胞的功能在体外更有效地控制Ftt复制的能力中得到证实。我们的观察强调了理解抗原特异性反应的重要性,因为包含一个能引起高亲和力的CD4 + T细胞的抗原决定簇将保护性较差的疫苗转化为能够提供100%保护的疫苗。综上所述,这些数据表明,要提高目前的Tularemia疫苗平台的功效,需要靶向适当的抗原特异性CD4 + T细胞反应,并阐明引起高亲和力CD4 + 成功开发疫苗将需要T细胞应答,特别是在人类中。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号